Published in J Med Econ on September 25, 2012
Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients. Transplantation (2014) 1.04
Big data in organ transplantation: registries and administrative claims. Am J Transplant (2014) 0.99
Decreasing Estimated Glomerular Filtration Rate Is Associated With Increased Risk of Hospitalization After Kidney Transplantation. KI Rep (2016) 0.75
Gestational hypertension and preeclampsia in living kidney donors. N Engl J Med (2014) 7.25
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med (2015) 5.03
Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation (2003) 4.52
Racial variation in medical outcomes among living kidney donors. N Engl J Med (2010) 3.60
Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004. Arch Intern Med (2007) 3.30
Liver transplantation cost in the model for end-stage liver disease era: looking beyond the transplant admission. Liver Transpl (2009) 2.38
The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation. Liver Transpl (2011) 1.79
Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review. Transplantation (2009) 1.75
Humanistic and economic impacts of hepatitis C infection in the United States. J Med Econ (2010) 1.72
Health insurance considerations for adolescent transplant recipients as they transition to adulthood. Pediatr Transplant (2007) 1.68
Acute dialysis risk in living kidney donors. Nephrol Dial Transplant (2012) 1.60
Assessment of racial disparities in chronic kidney disease stage 3 and 4 care in the department of defense health system. Clin J Am Soc Nephrol (2008) 1.56
Incidence, predictors and associated outcomes of rhabdomyolysis after kidney transplantation. Nephrol Dial Transplant (2009) 1.52
Race, Relationship and Renal Diagnoses After Living Kidney Donation. Transplantation (2015) 1.45
Transplant certification and quality assessment: time to take the front line? Prog Transplant (2013) 1.43
The interplay of socioeconomic status, distance to center, and interdonor service area travel on kidney transplant access and outcomes. Clin J Am Soc Nephrol (2010) 1.32
Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction--long-term results. Am J Transplant (2005) 1.29
Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation. Transplantation (2008) 1.27
Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors. Transplantation (2014) 1.22
Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol (2008) 1.21
Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality. Am J Kidney Dis (2008) 1.20
The implications of acute rejection for allograft survival in contemporary U.S. kidney transplantation. Transplantation (2012) 1.14
Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure. Transplantation (2006) 1.13
Agreement of immunosuppression regimens described in Medicare pharmacy claims with the Organ Procurement and Transplantation Network survey. J Am Soc Nephrol (2006) 1.13
Renal function and healthcare costs in patients with polycystic kidney disease. Clin J Am Soc Nephrol (2010) 1.10
Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol (2012) 1.09
The impact of transplantation with deceased donor hepatitis c-positive kidneys on survival in wait-listed long-term dialysis patients. Am J Transplant (2004) 1.07
Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation (2007) 1.06
A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study. Eur Psychiatry (2007) 1.05
Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients. Transplantation (2014) 1.04
Novel methods for tracking long-term maintenance immunosuppression regimens. Clin J Am Soc Nephrol (2007) 1.04
The implications of acute rejection and reduced allograft function on health care expenditures in contemporary US kidney transplantation. Transplantation (2012) 1.00
Tolerance-like mediated suppression by mesenchymal stem cells in patients with dust mite allergy-induced asthma. J Allergy Clin Immunol (2011) 1.00
The life-years saved by a deceased organ donor. Am J Transplant (2005) 1.00
Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider. Am J Kidney Dis (2011) 1.00
Kidney transplant Medicare payments and length of stay: associations with comorbidities and organ quality. Arch Med Sci (2011) 0.99
Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI. Neurobiol Aging (2012) 0.98
Review of patient-reported outcome measures in chronic hepatitis C. Health Qual Life Outcomes (2012) 0.98
The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913). BMC Psychiatry (2008) 0.98
Following the organ supply: assessing the benefit of inter-DSA travel in liver transplantation. Transplantation (2013) 0.98
The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study. Pharmacoepidemiol Drug Saf (2009) 0.98
Incidence, predictors and outcomes of transplant renal artery stenosis after kidney transplantation: analysis of USRDS. Am J Nephrol (2009) 0.97
Incidence, predictors, and associated outcomes of prostatism after kidney transplantation. Clin J Am Soc Nephrol (2009) 0.97
Risk of serious gastrointestinal bleeding in living kidney donors. Clin Transplant (2014) 0.96
The relationship between health perception and utility in heart failure patients in a clinical trial: results from an OVERTURE substudy. J Card Fail (2004) 0.96
Gestational hypertension and preeclampsia in living kidney donors. N Engl J Med (2015) 0.95
The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities. J Med Econ (2011) 0.94
Immune-complex deposits in "pauci-immune" glomerulonephritis: a case report and brief review of recent literature. Arch Med Sci (2010) 0.93
Depression diagnoses after living kidney donation: linking U.S. Registry data and administrative claims. Transplantation (2012) 0.92
Enhancing and sustaining empathy in medical students. Med Teach (2013) 0.92
National assessment of early biliary complications following liver transplantation: incidence and outcomes. Liver Transpl (2014) 0.91
Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus. J Am Soc Nephrol (2004) 0.90
Cardiac evaluation before kidney transplantation: a practice patterns analysis in Medicare-insured dialysis patients. Clin J Am Soc Nephrol (2008) 0.90
Influence of early posttransplantation prednisone and calcineurin inhibitor dosages on the incidence of new-onset diabetes. Clin J Am Soc Nephrol (2007) 0.89
The cost effectiveness of deceased organ donation. Transplantation (2005) 0.89
Weight gain and new onset diabetes associated with olanzapine and risperidone. J Gen Intern Med (2004) 0.88
Incidence, predictors, costs, and outcome of renal cell carcinoma after kidney transplantation: USRDS experience. Transplantation (2010) 0.88
Formation of downhill esophageal varices as a rare but serious complication of hemodialysis access: a case report and comprehensive literature review. Clin Exp Nephrol (2008) 0.88
Maintenance immunosuppression use and the associated risk of avascular necrosis after kidney transplantation in the United States. Transplantation (2005) 0.87
Health-related quality of life in kidney transplant patients with diabetes. Clin Transplant (2013) 0.87
Obesity and kidney transplant candidates: how big is too big for transplantation?. Am J Nephrol (2012) 0.86
The impact of kidney transplantation on heart failure risk varies with candidate body mass index. Am Heart J (2009) 0.86
Associations of renal function at 1-year after kidney transplantation with subsequent return to dialysis, mortality, and healthcare costs. Transplantation (2011) 0.86
Understanding antihypertensive medication use after living kidney donation through linked national registry and pharmacy claims data. Am J Nephrol (2014) 0.86
Use of beta-blockers and aspirin after myocardial infarction by patient renal function in the Department of Defense health care system. Am J Kidney Dis (2006) 0.86
Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma. Int J Cancer (2014) 0.85
Outcomes of Live Kidney Donors Who Develop End-Stage Renal Disease. Transplantation (2016) 0.84
Increased risk of graft failure in kidney transplant recipients after a diagnosis of dyspepsia or gastroesophageal reflux disease. Transplantation (2008) 0.84
Cancer diagnoses after living kidney donation: linking U.S. Registry data and administrative claims. Transplantation (2012) 0.84
The relationship between systolic blood pressure and cardiovascular risk--results of the Brisighella Heart Study. J Clin Hypertens (Greenwich) (2003) 0.82
Use of 12-month renal function and baseline clinical factors to predict long-term graft survival: application to BENEFIT and BENEFIT-EXT trials. Transplantation (2012) 0.82
Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis. Clin Ther (2009) 0.82
Incremental value of the pancreas allograft to the survival of simultaneous pancreas-kidney transplant recipients. Diabetes Care (2009) 0.82
Early outcomes of thymoglobulin and basiliximab induction in kidney transplantation: application of statistical approaches to reduce bias in observational comparisons. Transplantation (2009) 0.81
Quantifying prognostic impact of prescription opioid use before kidney transplantation through linked registry and pharmaceutical claims data. Transplantation (2015) 0.81
Associations of recipient illness history with hypertension and diabetes after living kidney donation. Transplantation (2011) 0.81
Gout after living kidney donation: correlations with demographic traits and renal complications. Am J Nephrol (2015) 0.80
The impact of human leukocyte antigen matching on transplant complications and immunosuppression dosage. Hum Immunol (2007) 0.80
Increasing incidence of new-onset diabetes after transplant among pediatric renal transplant patients. Transplantation (2009) 0.80
The Risk of Cardiovascular Disease Is Not Increasing Over Time Despite Aging and Higher Comorbidity Burden of Kidney Transplant Recipients. Transplantation (2017) 0.80
End-stage renal disease risk in live kidney donors: what have we learned from two recent studies? Curr Opin Nephrol Hypertens (2014) 0.79
National assessment of early biliary complications after liver transplantation: economic implications. Transplantation (2014) 0.79
Renal function following living, standard criteria deceased and expanded criteria deceased donor kidney transplantation: impact on graft failure and death. Transpl Int (2011) 0.79
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med (2016) 0.78
Associations of pre-transplant prescription narcotic use with clinical complications after kidney transplantation. Am J Nephrol (2015) 0.78
Recognition of downhill esophageal varices in hemodialysis patients requires a high index of clinical suspicion. Clin Exp Nephrol (2009) 0.78